Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study

Fig. 3

Disposition of the study participants and reasons for withdrawal. N, number of participants; AE, adverse event; SAE, serious adverse event (considered not causally related to study vaccination). 0–2–6 group was given vaccine at 0–2–6 months and placebo at 12 months; 0–2–12 group was given vaccine at 0–2–12 months and placebo at 6 months

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us